2010
DOI: 10.4161/cc.9.23.14059
|View full text |Cite
|
Sign up to set email alerts
|

Nek6 overexpression antagonizes p53-induced senescence in human cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
64
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(64 citation statements)
references
References 26 publications
0
64
0
Order By: Relevance
“…Several kinases that had been previously shown to regulate telomerase were also among the hits, confirming the specificity of the functional read-out of the HTS (6)(7)(8). Moreover several of the identified kinases have been found overexpressed in different human cancers and are now being exploited as potential targets for cancer therapeutics (20)(21)(22)(25)(26)(27)(28)(29). Subsequent validation experiments showed that modulation of some of these proteins resulted in perturbation of telomerase function and elicited phenotypic changes characteristic of telomere dysfunctions, suggesting that the proteins identified in our screen are likely true modifiers of telomerase.…”
Section: Discussionmentioning
confidence: 73%
See 1 more Smart Citation
“…Several kinases that had been previously shown to regulate telomerase were also among the hits, confirming the specificity of the functional read-out of the HTS (6)(7)(8). Moreover several of the identified kinases have been found overexpressed in different human cancers and are now being exploited as potential targets for cancer therapeutics (20)(21)(22)(25)(26)(27)(28)(29). Subsequent validation experiments showed that modulation of some of these proteins resulted in perturbation of telomerase function and elicited phenotypic changes characteristic of telomere dysfunctions, suggesting that the proteins identified in our screen are likely true modifiers of telomerase.…”
Section: Discussionmentioning
confidence: 73%
“…There is now substantial evidence that NEK2, NEK6, NEK7, and NEK9 regulate mitotic progression and mitotic spindle organization (24). Furthermore, high expression levels of NEK kinases have also been found in human cancers, such as breast and bladder cancers (25,26) and NEK kinases are now being pursued as potential therapeutic targets (27,28). Members of the MAPK superfamily were also selected given their diverse functions in a wide variety of biological processes (9,29).…”
Section: Resultsmentioning
confidence: 99%
“…NEK6 activity promotes anchorageindependent growth; depletion of NEK6 leads to death in cancer cell lines but is tolerated by normal fibroblasts (Nassirpour et al, 2010). Overexpression of NEK6 also inhibits p53-dependent cellular senescence (Jee et al, 2010). The molecular mechanisms that underlie these observations are unknown, and could reflect a nonmitotic function of NEK6.…”
Section: Box 2 Mitotic Kinases As Anti-cancer Targetsmentioning
confidence: 98%
“…NIMA (never in mitosis gene a)-related kinase 6 (NEK6; also called SID6-1512) is localized on chromosome 9q33-34 and is a serine/threonine kinase that belongs to the Neks (NIMArelated kinases) family, which has been implicated in mitosis control (30). Yin et al previously found that human Nek6 is required for metaphase-anaphase transition during cell cycle progression (31).…”
Section: Discussionmentioning
confidence: 99%